AutoNavi (AMAP) Navigation App Pre-Installed on Samsung Galaxy S III
Get Alerts AMAP Hot Sheet
Join SI Premium – FREE
AutoNavi Holdings Limited (Nasdaq: AMAP), announced that the Company's premium Navigation application has been pre-installed on Samsung's new flagship smartphone, the GALAXY S III, which was officially launched in China this month. The pre-installation is the latest achievement in the Company's ongoing partnership with Samsung, through which AutoNavi pre-installs its premium navigation and map apps on Samsung's mobile handsets and tablets in China.
The GALAXY S III, running on the latest Android™ Ice Cream Sandwich, boasts a 4.8-inch HD Super AMOLED touchscreen and a powerful applications processor, and makes for an engaging and seamless user experience and an ideal interface for AutoNavi's navigation and location-based services. In addition to comprehensive map data, 3-D views and real-time traffic information, AutoNavi's premium navigation app includes features designed specifically for the GALAXY S III, including a map layer of Samsung designated points-of-interest, user archives of favorite places, city-specific functions, smart search features, and mobile positioning through GPS, cell towers, and Wi-Fi.
The GALAXY S III, running on the latest Android™ Ice Cream Sandwich, boasts a 4.8-inch HD Super AMOLED touchscreen and a powerful applications processor, and makes for an engaging and seamless user experience and an ideal interface for AutoNavi's navigation and location-based services. In addition to comprehensive map data, 3-D views and real-time traffic information, AutoNavi's premium navigation app includes features designed specifically for the GALAXY S III, including a map layer of Samsung designated points-of-interest, user archives of favorite places, city-specific functions, smart search features, and mobile positioning through GPS, cell towers, and Wi-Fi.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pitney-Bowes (PBI) Announces CFO Transition Process
- FibroBiologics (FBLG) Reports Prelim Proof of Concept for Fibroblast-based Diabetes Treatment
- Cytek® Biosciences (CTKB) Names William McCombe Chief Financial Officer, 2024 Outlook Reaffirmed
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!